1. Search Result

Search Result

Pathways Recommended: MAPK/ERK Pathway
Targets Recommended: p38 MAPK Neprilysin MAP4K MNK MAPKAPK2 (MK2)

Results for "10 μm p38 mapk Inhibitors" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-16558
    Butein

    2’,3,4,4’-tetrahydroxy Chalcone

    EGFR Autophagy Apoptosis Phosphodiesterase (PDE) Cancer
    Butein, isolated from Dalbergia odorifera T. Chen, is a cAMP-specific PDE inhibitor with an IC50 of 10.4 μM for PDE4. Butein is a specific protein tyrosine kinase inhibitor with IC50s of 16 and 65 μM for EGFR and p60 c-src in HepG2 cells. Butein sensitizes HeLa cells to Cisplatin through AKT and ERK/p38 MAPK pathways by targeting FoxO3a. Butein is a SIRT1 activator (STAC).